• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Admin

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Forum Topics Started

Viewing 2 topics - 1 through 2 (of 2 total)
    • Topic
    • Voices
    • Posts
    • Last Post
    • Coronavirus (COVID-19)

      Started by: Admin in: Member Forum

    • 0
    • 1
    • 6 years, 6 months ago

      Admin

    • Forum Guidelines

      Started by: Admin in: Member Forum

    • 1
    • 1
    • 10 years, 2 months ago

      Admin

  •  

Viewing 2 topics - 1 through 2 (of 2 total)

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Oct 15
9:00 am - 10:00 am EDT

Webinar: The Use of AI in ALS/MND

Oct 17
2:00 pm - 3:00 pm EDT

ALS Association Webinar: So, What’s Next? Understanding the Decisions along an ALS Journey

Oct 21
7:00 am - 8:30 am EDT

Member Roundtable: Defining Rights in the Genetics Era of ALS/MND

Oct 22
1:00 pm - 2:00 pm CDT

Les Turner ALS Foundation: The Access for ALL in ALS Consortium

Oct 27
2:00 pm - 3:00 pm EDT

ALS Association Webinar: An Honest Look at Hospice and ALS

View Calendar

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Ali Var, Turkey

    Ali Var, Turkey

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Timmy, Belgium

    Timmy, Belgium

  • Susan Anderson, USA

    Susan Anderson, USA

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Anita Forte, USA

    Anita Forte, USA

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Jack Buzby, USA

    Jack Buzby, USA

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Jay Epstein, USA

    Jay Epstein, USA

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • David Hall, USA

    David Hall, USA

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Fayette Underwood, USA

    Fayette Underwood, USA

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Luis Antonio Pimenta Lima, Brazil

    Luis Antonio Pimenta Lima, Brazil

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login